Effect of fluvastatin on the expression of myocardial IL-1β in rats with heart failure after acute myocardial infarction

Chinese Pharmacological Bulletin

Volumn 22, Issue 3, 2006, Pages 361-365

  Liu, Yu Hong ^a   Zeng, Qiu Lang ^a   Chen, Bin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Heart failure; HMG CoA reductase inhibitor; IL 1

Indexed keywords

COLLAGEN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 1BETA; MESSENGER RNA; SODIUM;

ACUTE HEART INFARCTION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DECELERATION; DRUG EFFECT; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART RIGHT VENTRICLE PRESSURE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEMODYNAMICS; LEFT CORONARY ARTERY; NONHUMAN; PROTEIN EXPRESSION; RAT; SURVIVAL RATE;

EID: 33745451316     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Hasegawa H, Yamamoto R, Takano H, et al. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors prevent the development of cardiac hypertrophy and heart failure in rats [J]. J Mol Cell Cardiol, 2003, 35(8):953-60.
2. Ono K, Matsumori A, Shioi T, et al. Cytokine gene expression after myocardial infarction in rat hearts : Possible implication in left ventricular remodeling[J]. Circulation, 1998, 98(2):149-56.
3. Di Iorio A, Ferrucci L, Sparvieri E, et al. Serum IL-1 beta levels in health and disease: A population-based study. 'The InCHIANTI study' [J]. Cytokine, 2003, 22(6):198-205.
4. Nozaki N, Shishido T, Takeishi Y, Kubota I. Modulation of doxorubicin- induced cardiac dysfunction in toll-like receptor-2-knock-out mice[J]. Circulation, 2004, 110(18):2869-74.
5. Hayashidani S, Tsutsui H, Shiomi T, et al. Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardi-al infarction [J]. Circulation, 2002, 105:868-73
6. Thaik CM, Calderone A, Takahashi N, et al. Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes[J]. J Clin Inves, 1995, 96:1093-9.
7. Hinglais N, Heudes D, Nicoletti A, et al. Colocalization of myocardial fibrosis and inflammatory cells in rats [J]. Lab Invest, 1994, 70:286-94.
8. Pinsky DJ, Cai B, Yang X, et al. The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta [J]. J Clin Invest, 1995, 95(2):677-85.
9. 2+ current by interleukin-1 beta in cultured rat ventricular myocytes[J]. Am J Physio, 1995, 268:C339-49.
10. Hosenpud J D. The effects of interleukin 1 on myocardial function and metabolism [J]. Clin Immunol Immunopathol, 1993, 68:175-80.
11. Pulkki K J. Cytokines and cardiomyocyte death [J]. Ann Med, 1997, 29:339-43.
12. Inoue I, Goto S, Mizotani K, et al. Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect ; Reduction of mRNA levels for interleukin-1 beta, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferators-activated receptor alpha (PPARalpha) in primary endothelial cells [J]. Life Sci, 2000, 67:863-76.
13. Shiomi T, Tsutsui H, Hayashidani S, et al. Pioglitazone, a peroxi-some proliferatoractivated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction[J]. Circulation, 2002, 106:3126-32.
14. Ortego M, Bustos C, Hernandez-Presa M A, et al. Atorvastatin reduces NF-kappa B activation and chemokine expression in vascular smooth muscle cells and mononuclear cells [J]. Atherosclerosis, 1999, 13(2):253-61.